Interventional Oncology Market - Global Industry Analysis

Interventional Oncology Market By Product (Embolization Devices, Ablation Devices, and Support Devices), By Cancer Type (Kidney, Lung, Breast, Liver, Bone Metastasis, and Others), and By Procedure (Thermal Ablation, Non-Thermal Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization, and Transcatheter Arterial Embolization): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 18-Sep-2019 Category: Healthcare Report Format : PDF Pages: 150 Report Code: ZMR-4093 Status : Published

Global interventional oncology market is expected to generate around USD 3,145 million by 2025, at a CAGR of around 7.6% between 2019 and 2025. Interventional oncology is a field of interventional radiology that deals with the treatment and diagnosis of primary or metastatic cancers.

Description

Interventional Oncology Market: Overview

The report analyzes and forecasts the interventional oncology market on a global and regional level. The study offers past data from 2017 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The assessment of interventional oncology market dynamics gives a brief thought about the drivers and restraints of the interventional oncology market along with their impact on the demand over the years to come. Additionally, the report also includes the study of opportunities available in the interventional oncology market on a global level.

The report gives a transparent view of the interventional oncology market. We have included a detailed competitive scenario and portfolio of the leading vendors operating in the interventional oncology market. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces Model for the interventional oncology market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Interventional Oncology Market

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The interventional oncology market is fragmented on the basis of product, cancer type, procedure, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players involved in the interventional oncology market are Boston Scientific, Terumo Corporation, Medtronic, BTG, Ethicon, AngioDynamics, Merit Medical Systems, Sirtex Medical, Eckert & Ziegler, BEBIG, Siemens Healthineers, Varian Medical Systems, and HealthTronics.

This report segments the global interventional oncology market into:

Global Interventional Oncology Market: Product Analysis

  • Embolization Devices
  • Radioembolic Agents
  • Non-Radioactive Agents
  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Others
  • Support Devices
  • Guidewires
  • Microcatheter

Global Interventional Oncology Market: Cancer Type Analysis

  • Kidney Cancer
  • Lung Cancer
  • Breast Cancer
  • Liver Cancer
  • Bone Metastasis Cancer
  • Others

Global Interventional Oncology Market: Procedure Analysis

  • Thermal Tumor Ablation
  • Non-Thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization
  • Transcatheter Arterial Radioembolization
  • Transcatheter Arterial Embolization

Global Interventional Oncology Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Interventional Oncology Market, 2017-2025 (USD Million)
    • 2.2. Interventional Oncology Market: Snapshot
  •  
  • Chapter 3. Interventional Oncology Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Rapid Growth in the Geriatric Population
      • 3.2.2. Technological advancements
      • 3.2.3. Increasing government initiatives for cancer treatment
      • 3.2.4. Increasing awareness in developing nations
      • 3.2.5. Advanced research and development
      • 3.2.6. Increase in cancer patients due to changing lifestyle
      • 3.2.7. Growing elderly population
    • 3.3. Market restraints
      • 3.3.1. The high cost of treatment
      • 3.3.2. Lack of awareness in underdeveloped countries
      • 3.3.3. Lack of proper reimbursement policies
    • 3.4. Opportunities
      • 3.4.1. Evolving market
      • 3.4.2. Advanced technology
      • 3.4.3. Untapped Emerging Market
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product
      • 3.6.2. Market attractiveness analysis, by cancer type
      • 3.6.3. Market attractiveness analysis, by procedure
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Interventional Oncology Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Interventional oncology market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New instruments launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Interventional Oncology Market - Product Analysis
    • 5.1. Interventional oncology market: Product overview
      • 5.1.1. Interventional oncology Market Revenue, by product, 2018 and 2025
    • 5.2. Embolization Devices
      • 5.2.1. Interventional oncology market for embolization devices, 2017-2025 (USD Million)
    • 5.3. Ablation Devices
      • 5.3.1. Interventional oncology market for ablation devices, 2017-2025 (USD Million)
    • 5.4. Support Devices
      • 5.4.1. Interventional oncology market for support devices, 2017-2025 (USD Million)
  •  
  • Chapter 6. Interventional Oncology Market - Cancer Type Analysis
    • 6.1. Interventional oncology market: Cancer type overview
      • 6.1.1. Interventional oncology Market Revenue, by cancer type, 2018 and 2025
    • 6.2. Kidney
      • 6.2.1. Interventional oncology market for kidney cancer, 2017-2025 (USD Million)
    • 6.3. Lung
      • 6.3.1. Interventional oncology market for lung cancer, 2017-2025 (USD Million)
    • 6.4. Breast
      • 6.4.1. Interventional oncology market for breast cancer, 2017-2025 (USD Million)
    • 6.5. Liver
      • 6.5.1. Interventional oncology market for liver cancer, 2017-2025 (USD Million)
    • 6.6. Bone Metastasis
      • 6.6.1. Interventional oncology market for bone metastasis cancer, 2017-2025 (USD Million)
    • 6.7. Others
      • 6.7.1. Interventional oncology market for others, 2017-2025 (USD Million)
  •  
  • Chapter 7. Interventional Oncology Market - Procedure Analysis
    • 7.1. Interventional oncology market: procedure overview
      • 7.1.1. Interventional oncology market revenue, by procedure, 2018 and 2025
      • 7.1.2. Thermal Ablation
        • 7.1.2.1. Interventional oncology market for thermal ablation, 2017-2025 (USD Million)
      • 7.1.3. Non-Thermal Ablation
        • 7.1.3.1. Interventional oncology market for non-thermal ablation, 2017-2025 (USD Million)
      • 7.1.4. Transcatheter Arterial Chemoembolization
        • 7.1.4.1. Interventional oncology market for transcatheter arterial chemoembolization, 2017-2025 (USD Million)
      • 7.1.5. Transcatheter Arterial Radioembolization
        • 7.1.5.1. Interventional oncology market for transcatheter arterial radioembolization, 2017-2025 (USD Million)
      • 7.1.6. Transcatheter Arterial Embolization
        • 7.1.6.1. Interventional oncology market for transcatheter arterial embolization, 2017-2025 (USD Million)
  •  
  • Chapter 8. Interventional Oncology Market - Regional Analysis
    • 8.1. Global interventional oncology market: Regional overview
      • 8.1.1. Interventional oncology market revenue, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.2.2. North America interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.2.3. North America interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. interventional oncology market, by product, 2017-2025 (USD Million)
        • 8.2.4.2. The U.S. interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.2.4.3. The U.S. interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada interventional oncology market, by product, 2017-2025 (USD Million)
        • 8.2.5.2. Canada interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.2.5.3. Canada interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.3.2. Europe interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.3.3. Europe interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.3.4. UK
        • 8.3.4.1. UK interventional oncology market, by product, 2017-2025 (USD Million)
        • 8.3.4.2. UK interventional oncology market, by cancer type, 2017-2025 (USD Million)
        • 8.3.4.3. UK interventional oncology market, by procedure, 2017-2025 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.3.5.2. Germany interventional oncology market, by cancer type, 2017-2025 (USD Million)
        • 8.3.5.3. Germany interventional oncology market, by procedure, 2017-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.3.6.2. France interventional oncology market, by cancer type, 2017-2025 (USD Million)
        • 8.3.6.3. France interventional oncology market, by procedure, 2017-2025 (USD Million)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.3.7.2. Rest of Europe interventional oncology market, by cancer type, 2017-2025 (USD Million)
        • 8.3.7.3. Rest of Europe interventional oncology market, by procedure, 2017-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.4.2. Asia Pacific interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.4.3. Asia Pacific interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.4.4.2. China interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.4.4.3. China interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan interventional oncology market revenue, byproduct, 2017-2025 (USD Million)
        • 8.4.5.2. Japan interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.4.5.3. Japan interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.4.6.2. India interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.4.6.3. India interventional oncology market revenue, by procedure type, 2017-2025 (USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.4.7.2. Rest of Asia Pacific interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.4.7.3. Rest of Asia Pacific interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.5.2. Latin America interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.5.3. Latin America interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.5.4.2. Brazil interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.5.4.3. Brazil interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.5.5.2. Rest of Latin America interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.5.5.3. Rest of Latin America interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.6.2. The Middle East and Africa interventional oncology market, by cancer type, 2017-2025 (USD Million)
      • 8.6.3. The Middle East and Africa interventional oncology market, by procedure, 2017-2025 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Boston Scientific
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Terumo Corporation
      • 9.2.1. overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Medtronic
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. BTG
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Ethicon
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. AngioDynamics
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Merit Medical Systems
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Sirtex Medical
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Eckert & Ziegler
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. BEBIG
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Interventional Oncology Market, 2017–2025 (USD Million) 
4. Porter’s Five Forces Analysis
5. Interventional oncology market attractiveness analysis, by product
6. Interventional oncology market attractiveness analysis, by cancer type
7. Interventional oncology market: attractiveness analysis, by procedure
8. Interventional oncology market: attractiveness analysis, by region
9. Company market share analysis, 2018
10. Interventional oncology market revenue by product, 2018 and 2025
11. Interventional oncology market for embolization devices, 2017–2025 (USD Million)
12. Interventional oncology market for ablation devices, 2017–2025 (USD Million)
13. Interventional oncology market for support devices, 2017–2025 (USD Million)
14. Interventional oncology market revenue by cancer type, 2018 and 2025
15. Interventional oncology market revenue share by kidney, 2017–2025 (USD Million)
16. Interventional oncology market revenue share by lung, 2017–2025 (USD Million)
17. Interventional oncology market revenue share by breast, 2017–2025 (USD Million)
18. Interventional oncology market revenue share by liver, 2017–2025 (USD Million)
19. Interventional oncology market revenue share by bone metastasis, 2017–2025 (USD Million)
20. Interventional oncology market revenue share by others, 2017–2025 (USD Million)
21. Interventional oncology market revenue share by procedure, 2018 and 2025
22. Interventional oncology market revenue share by thermal tumor ablation, 2017–2025 (USD Million)
23. Interventional oncology market revenue share by non-thermal tumor ablation, 2017–2025 (USD Million)
24. Interventional oncology market revenue share by Transcatheter Arterial Chemoembolization, 2017–2025 (USD Million)
25. Interventional oncology market revenue share by Transcatheter Arterial Radioembolization, 2017–2025 (USD Million)
26. Interventional oncology market revenue share by Transcatheter Arterial Embolization, 2017–2025 (USD Million)
27. North America Interventional oncology market, 2017–2025 (USD Million)
28. Europe Interventional oncology market, 2017–2025 (USD Million)
29. Asia Pacific Interventional oncology market, 2017–2025 (USD Million)
30. Latin America Interventional oncology market,2017–2025 (USD Million)
31. The Middle East and Africa Interventional oncology market, 2017–2025 (USD Million)


Table Of Tables

List of Tables

1. Interventional oncology market: Snapshot
2. Drivers of the Interventional oncology market: Impact analysis
3. Restraints of the Interventional oncology market: Impact analysis
4. North America Interventional oncology market revenue, by product, 2017–2025 (USD Million)
5. North America interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
6. North America interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
7. The U.S. interventional oncology market revenue, by product, 2017–2025 (USD Million)
8. The U.S. interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
9. The U.S. interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
10. Canada interventional oncology market revenue, by product, 2017–2025 (USD Million)
11. Canada interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
12. Canada interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
13. Europe interventional oncology market revenue, by product, 2017–2025 (USD Million)
14. Europe interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
15. Europe interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
16. UK interventional oncology market revenue, by product, 2017–2025 (USD Million)
17. UK interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
18. UK interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
19. Germany interventional oncology market revenue, by product, 2017–2025 (USD Million)
20. Germany interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
21. Germany interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
22. France interventional oncology market revenue, by product, 2017–2025 (USD Million)
23. France interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
24. France interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
25. Rest of Europe interventional oncology market revenue, by product, 2017–2025 (USD Million)
26. Rest of Europe interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
27. Rest of Europe interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
28. Asia Pacific interventional oncology market revenue, by product, 2017–2025 (USD Million)
29. Asia Pacific interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
30. Asia Pacific interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
31. China interventional oncology market revenue, by product, 2017–2025 (USD Million)
32. China interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
33. China interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
34. Japan interventional oncology market revenue, by product, 2017–2025 (USD Million)
35. Japan interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
36. Japan interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
37. India interventional oncology market revenue, by product, 2017–2025 (USD Million)
38. India interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
39. India interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
40. Rest of Asia Pacific interventional oncology market revenue, by product, 2017–2025 (USD Million)
41. Rest of Asia Pacific interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
42. Rest of Asia Pacific interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
43. Latin America interventional oncology market revenue, by product, 2017–2025 (USD Million)
44. Latin America interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
45. Latin America interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
46. Brazil interventional oncology market revenue, by product, 2017–2025 (USD Million)
47. Brazil interventional oncology market revenue, by cancer type, 2017–2025 (USD Millions)
48. Brazil interventional oncology market revenue, by procedure, 2017-2025 (USD Millions)
49. Rest of Latin America interventional oncology market revenue, by product, 2017–2025 (USD Million)
50. Rest of Latin America interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
51. Rest of Latin America interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
52. The Middle East and Africa interventional oncology market revenue, by product, 2017–2025 (USD Million)
53. The Middle East and Africa interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
54. The Middle East and Africa interventional oncology market revenue, by procedure, 2017–2025 (USD Million)

Methodology

Free Analysis

Interventional oncology is a field of interventional radiology that deals with the treatment and diagnosis of primary or metastatic cancers, such as kidney, liver, bone, lung, etc. As the process is minimally invasive in nature, the recovery time required is less. Interventional oncology is among the most promising and rapidly growing branch of interventional radiology. This procedure is mostly used for patients who are not eligible for chemotherapy.

According to international agencies for cancer research, in 2018, about 18.1 million new cancer patients were reported across the world. Additionally, every sixth global death is due to cancer, thus making it the second death cause globally. Escalating cancer patients, increasing elderly population, and rising cancer risk among youth due to unhealthy habits like smoking, chewing tobacco, and alcohol will drive the interventional oncology market in the future. A significant rise in disposable income, increase in cancer awareness, and high adoption of technological advancements are expected to create additional growth opportunities for the interventional oncology market in the years ahead. Improvements in the R&D process, presence of giant companies with advanced technologies and active marketing channels, ongoing developments of the healthcare infrastructure, increasing government initiatives are further stimulating the interventional oncology market growth. However, high treatment cost and adverse effects of chemotherapy drugs on patients may limit this global market.

Global Interventional Oncology Market

On the basis of product, the market includes embolization devices (radioembolic and non-radioactive agents), ablation devices (cryoablation devices, radiofrequency ablation devices, microwave ablation devices, and others), and support devices (microcatheters and guidewires). By cancer type, the interventional oncology market includes kidney, liver, lung, bone metastasis, breast, and other cancers. Based on procedure, the market comprises thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization, transcatheter arterial embolization, and transcatheter arterial radioembolization.

North America dominated the interventional oncology market in 2018, due to the considerably high number of cancer surgeries, especially in the U.S. In 2018, about 1.7 million new cancer cases were diagnosed and nearly around 6.5 lakh people died in the same year in the U.S. The Asia Pacific interventional oncology market is expected to record the highest CAGR in the upcoming years, as the developing economies of India, China, and South Korea and the developed economies of Japan and Australia are offering several opportunities for regional expansion to global market players.

Some major players involved in the interventional oncology market are Boston Scientific, Terumo Corporation, Medtronic, BTG, Ethicon, AngioDynamics, Merit Medical Systems, Sirtex Medical, Eckert & Ziegler, BEBIG, Siemens Healthineers, Varian Medical Systems, and HealthTronics.

Choose License Type

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed